The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1042264334 10422643 34 F 20140227 20160921 20140902 20160927 EXP CA-ROCHE-1430654 ROCHE 43.51 YR M Y 100.00000 KG 20160928 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1042264334 10422643 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous 375 MG, BIW (EVERY 2 WEEKS) D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 375 MG SOLUTION FOR INJECTION QOW
1042264334 10422643 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 7 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 8 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 9 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 10 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 11 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 12 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 13 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 14 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 15 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 16 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 17 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 18 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 19 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 20 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 21 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 22 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 23 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 24 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 25 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 26 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 27 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 28 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 29 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 30 SS XOLAIR OMALIZUMAB 1 Subcutaneous D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 31 SS XOLAIR OMALIZUMAB 1 Subcutaneous D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 32 SS XOLAIR OMALIZUMAB 1 Subcutaneous D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 33 SS XOLAIR OMALIZUMAB 1 Subcutaneous D S0062,S0059B,S0060,S0065E,S0066B,S0 103976 SOLUTION FOR INJECTION
1042264334 10422643 34 SS PREDNISONE. PREDNISONE 1 Unknown D 0 25 MG QD
1042264334 10422643 35 SS PREDNISONE. PREDNISONE 1 Unknown 25 MG, QD D 0 20 MG QD
1042264334 10422643 36 SS PREDNISONE. PREDNISONE 1 Unknown 5 MG, QW D 0 35 MG QD
1042264334 10422643 37 SS PREDNISONE. PREDNISONE 1 Unknown 20 MG, QD D 0 20 MG QD
1042264334 10422643 38 SS PREDNISONE. PREDNISONE 1 Unknown 25 MG, QD (TAPERED TO 20 MG OVER 2 WEEKS AND THEN TO 10 MG) D 0 25 MG QD
1042264334 10422643 39 SS PREDNISONE. PREDNISONE 1 Unknown 20 MG, UNK D 0 5 MG /wk
1042264334 10422643 40 SS PREDNISONE. PREDNISONE 1 Unknown 25 MG, QD (TAPERED TO 20 MG OVER 2 WEEKS AND THEN TO 10 MG) D 0 25 MG QD
1042264334 10422643 41 SS PREDNISONE. PREDNISONE 1 Oral D 0
1042264334 10422643 42 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Unknown U 0
1042264334 10422643 43 C ALVESCO CICLESONIDE 1 Unknown U 0
1042264334 10422643 44 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown U 0
1042264334 10422643 45 C SINGULAIR MONTELUKAST SODIUM 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1042264334 10422643 1 Asthma
1042264334 10422643 34 Wheezing
1042264334 10422643 35 Cough
1042264334 10422643 36 Throat tightness
1042264334 10422643 42 Product used for unknown indication
1042264334 10422643 43 Product used for unknown indication
1042264334 10422643 44 Product used for unknown indication
1042264334 10422643 45 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
1042264334 10422643 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
1042264334 10422643 Arthralgia
1042264334 10422643 Asthma
1042264334 10422643 Blood pressure increased
1042264334 10422643 Body temperature decreased
1042264334 10422643 Bronchitis
1042264334 10422643 Chest pain
1042264334 10422643 Dizziness
1042264334 10422643 Dizziness postural
1042264334 10422643 Dyspnoea exertional
1042264334 10422643 Eating disorder
1042264334 10422643 Fall
1042264334 10422643 Fractured coccyx
1042264334 10422643 Gait disturbance
1042264334 10422643 Gastroenteritis viral
1042264334 10422643 Headache
1042264334 10422643 Heart rate increased
1042264334 10422643 Heart rate irregular
1042264334 10422643 Herpes zoster
1042264334 10422643 Malaise
1042264334 10422643 Migraine
1042264334 10422643 Neck pain
1042264334 10422643 Pneumonia
1042264334 10422643 Respiratory tract irritation
1042264334 10422643 Rib fracture
1042264334 10422643 Sneezing
1042264334 10422643 Swelling
1042264334 10422643 Throat tightness
1042264334 10422643 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1042264334 10422643 1 20140227 0
1042264334 10422643 2 20140326 0
1042264334 10422643 3 20140409 0
1042264334 10422643 4 20140521 0
1042264334 10422643 5 20140604 0
1042264334 10422643 6 20140702 0
1042264334 10422643 7 20140716 0
1042264334 10422643 8 20140813 0
1042264334 10422643 9 20140827 0
1042264334 10422643 10 20141217 0
1042264334 10422643 11 20141230 0
1042264334 10422643 12 20150114 0
1042264334 10422643 13 20150129 0
1042264334 10422643 14 20150225 0
1042264334 10422643 15 20150311 0
1042264334 10422643 16 20150325 0
1042264334 10422643 17 20150506 0
1042264334 10422643 18 20150603 0
1042264334 10422643 19 20150715 0
1042264334 10422643 20 20151202 0
1042264334 10422643 21 20160127 0
1042264334 10422643 22 20160224 0
1042264334 10422643 23 20160309 0
1042264334 10422643 24 20160323 0
1042264334 10422643 25 20160504 0
1042264334 10422643 26 20160518 0
1042264334 10422643 27 20160601 0
1042264334 10422643 28 20160615 0
1042264334 10422643 29 20160629 0
1042264334 10422643 30 20160713 0
1042264334 10422643 31 20160825 0
1042264334 10422643 32 20160907 0
1042264334 10422643 33 20160921 0
1042264334 10422643 34 20140627 0
1042264334 10422643 35 20140827 0
1042264334 10422643 36 20141022 0
1042264334 10422643 37 20150426 0
1042264334 10422643 38 20141022 0
1042264334 10422643 39 20150426 0

Execution Time: 0.0080540180206299 seconds (ucode:5263678). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.